New Lifecycle Management Opportunities
Effective product life cycle management is a critical survival strategy today, as pharmaceutical and biotechnology companies compete to maintain market share and maximize commercial returns. PDG Technology™ can extend patent life and brand franchises.
Orally Disintegrating and Fixed-Dose Tablets to Extend Product Lifetime
Development of ODTs can be a highly cost effective way of creating branded, differentiated line extensions. A new dosage form allows a manufacturer to protect market share, while improving patient compliance.
Pharmaceutical manufacturers are also increasingly interested in developing FDCs offering clinical benefits and/or reduced risk while also improving patient compliance and extending the life cycle of established therapies.
Reformulate Archived Products
PDG Technology™ can be used to granulate virtually any API, offering a pharmaceutical company the opportunity to reformulate products that have failed in development due to formulation issues. For example, wet granulation or direct compression may require such large quantities of excipients that the tablet eventually becomes too large to be swallowed. With PDG Technology™, much higher drug loads and therefore smaller tables can be achieved.